Rosuvastatin Completed Phase 3 Trials for Congestive Heart Failure Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00240292Rosuvastatin Impact on Ventricular Remodelling Lipids and Cytokines